Warning from WHO: Fake ‘Skinny Jabs’ Can Be Harmful or Deadly
The World Health Organization (WHO) has raised concerns about counterfeit versions of the off-label weight-loss drug Ozempic being found in the supply chain of countries like the UK.
Ozempic, a type 2 diabetes medication, has been repurposed for weight loss due to its blood sugar regulating and appetite-suppressing properties.
While Ozempic is not officially approved as a weight loss drug on the NHS, unauthorized “skinny jabs” are easily accessible in the UK for individuals seeking to lose weight.
In 2023, three falsified batches of the drug were detected in the US, UK, and Brazil, prompting WHO to issue a warning on June 20.
Dr. Yukiko Nakatani, WHO assistant director-general for access to medicines, stated, “These falsified products could have harmful effects on people’s health, potentially leading to complications from unmanaged blood glucose levels or weight issues.”
Fake Ozempic, along with similar weight-loss drugs like Wegovy and Mounjaro, can pose serious health risks if they contain undisclosed or incorrect active ingredients.
Off-Label Prescribing and Risks
Although Ozempic has been available on the NHS for type 2 diabetics since 2019, it is now being misused for weight loss purposes through off-label prescribing.
Wegovy was approved for weight loss in obese individuals with related health conditions in 2022, but unauthorized access to weight loss injections remains a concern.
Despite the surge in demand for these drugs, fueled by social media influencers and celebrities, potential side effects like vomiting, diarrhea, and fatigue have been reported.
Online Availability and Safety Concerns
The NHS and WHO have cautioned against obtaining weight loss medications from online sources, as counterfeit versions may lack the necessary components and pose serious health risks.
Reports of seizures and comas from injecting fake weight loss drugs have prompted health officials to urge the public to report any suspected counterfeit medicines.
Novo Nordisk, the manufacturer of Ozempic, has confirmed the presence of counterfeit batches in circulation and advised caution when purchasing weight loss medications.
Health care professionals, regulatory authorities, and the public are encouraged to report any suspect products to relevant authorities to ensure the safety and efficacy of weight loss treatments.
Please rewrite this sentence.
Source link
